A study by Roy Hamilton of the Perelman School of Medicine and colleagues suggests that the drug lecanemab may slow the progression of Alzheimer’s or forestall its effects before they occur.
https://cbsn.ws/3Y4k2KF CBS PhiladelphiaA study by Roy Hamilton of the Perelman School of Medicine and colleagues suggests that the drug lecanemab may slow the progression of Alzheimer’s or forestall its effects before they occur.
https://cbsn.ws/3Y4k2KF CBS Philadelphia